Evidence map›Paper›PMID 23061030›Full record

ArticleAdvanced healthcare materials2012

Dual-imaging enabled cancer-targeting nanoparticles.

Aniket S Wadajkar, Tejaswi Kadapure, Yi Zhang, Weina Cui, Kytai T Nguyen, Jian Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced healthcare materials, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Citrate-Based Fluorescent Biomaterials.Advanced healthcare materials · 2018
    Review
  13. Review
  14. Bioactive materials · 2018
    Article
  15. Article
  16. Review
  17. Article
  18. Polymeric nanoparticles for targeted radiosensitization of prostate cancer cells.Journal of biomedical materials research. Part A · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aniket S WadajkarDepartment of Bioengineering, The University of Texas at Arlington, 500 UTA Boulevard, Arlington, TX 76019, USA.
Tejaswi Kadapure
Yi Zhang
Weina Cui
Kytai T Nguyen
Jian Yang

Funding

Creating Safe Biodegradable Photoluminescent Implant PolymersR01EB012575 · NIBIB · UNIVERSITY OF TEXAS ARLINGTON · PI YANG, JIAN · 2011 to 2014
$1.2M
Enabling aliphatic biodegradable photoluminescent polymeric biomaterialsR21EB009795 · NIBIB · UNIVERSITY OF TEXAS ARLINGTON · PI YANG, JIAN · 2009 to 2010
$404k
NIBIB NIH HHS R01 EB012575NIBIB NIH HHS R01EB012575NIBIB NIH HHS R21 EB009795NIBIB NIH HHS R21EB009795
6 · The paper itself

Abstract

The development of dual-imaging enabled cancer-targeting nanoparticles (DICT-NPs) is reported based on newly developed biodegradable photoluminescent polymers and superparamagnetic iron oxide nanoparticles. DICT-NPs possess capabilities of dual-imaging (magnetic resonance imaging and optical imaging), magnetic targeting, and potentially selective targeting for cancer cells. The development of DICT-NPs address the concerns in dual-imaging nanoparticles where photobleaching organic dyes and cytotoxic quantum dots are usually adopted.

Indexed as

NanoparticlesSubtraction TechniqueCell Line, TumorContrast MediaHumansMagnetic Resonance ImagingMaleMicroscopy, FluorescenceProstatic NeoplasmsContrast Media

Identifiers

PMID23061030
PMCPMC3466609

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.